Sandoz Canada Expands Its Portfolio With Generic Vyvanse Launch
In Spring, The Firm Also Launched Generic Amoxicillin, Desvenlafaxine, And Riociguat
Sandoz Canada brings a lisdexamfetamine generic to the market, while its US filing still has tentative approval. Meanwhile, off-patent group CGPA launches a social media campaign to tackle misinformation surrounding generics.
